Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.


In the US, Valsartan (valsartan systemic) is a member of the drug class angiotensin receptor blockers and is used to treat Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Name


Foreign Names

  • Valsartanum (Latin)
  • Valsartan (German)
  • Valsartan (French)
  • Valsartán (Spanish)

Generic Names

  • Valsartan (OS: USAN, BAN, DCF, JAN)
  • CGP 48933 (IS: Ciba-Geigy)
  • Valsartan (PH: BP 2016, JP XVI, Ph. Eur. 8, USP 38)
  • Valsartanum (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.